Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Mufti

Showing results (171-180 of 202) with videos related to

Pageof 21
Sort By:
British Journal of Cancer|July 1, 1996
The effect of combined expression of interleukin 2 and interleukin 4 on the tumorigenicity and treatment of B16F10 melanomaS J Hollingsworth, D Darling, J Gäken, et al.
Cancer Genetics and Cytogenetics|January 12, 2005
Isochromosome of a deleted 20q: a rare but recurrent chromosome abnormality in myelodysplastic syndromesK Saunders, B Czepulkowski, R Sivalingam, et al.
Leukemia Research|January 1, 1987
Differentiation induction in myelodysplasia and acute myeloid leukaemia: use of synergistic drug combinationsG E Francis, G J Mufti, S M Knowles, et al.
Oncogene|May 5, 2010
Reducing MCM levels in human primary T cells during the G(0)-->G(1) transition causes genomic instability during the first cell cycleS J Orr, T Gaymes, D Ladon, et al.
European Journal of Haematology|November 30, 2005
Cardiac presentation of ALK positive anaplastic large cell lymphomaZ Y Lim, R Grace, J R Salisbury, et al.
Bone Marrow Transplantation|February 27, 2007
Sarcoidosis as an unusual cause of hepatic dysfunction following reduced intensity conditioned allogeneic stem cell transplantationL Gooneratne, Z Y Lim, A du Vivier, et al.
Bone Marrow Transplantation|January 26, 2010
Allogeneic haematopoietic SCT for chronic myelomonocytic leukaemia: a single-centre experienceP Krishnamurthy, Z Y Lim, W Nagi, et al.
Leukemia Research|December 1, 2009
Impact of pre-transplant serum ferritin on outcomes of patients with myelodysplastic syndromes or secondary acute myeloid leukaemia receiving reduced intensity conditioning allogeneic haematopoietic stem cell transplantationZ Y Lim, V Fiaccadori, S Gandhi, et al.
The British Journal of Dermatology|April 11, 2007
Sclerodermatous graft-versus-host disease: clinical spectrum and therapeutic challengesJ M L White, D Creamer, A W P du Vivier, et al.
Blood|January 1, 1989
Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell originJ W Janssen, M Buschle, M Layton, et al.
Pageof 21

Showing results (171-180 of 202) with videos related to

Sort By:
Pageof 21
British Journal of Cancer|July 1, 1996
The effect of combined expression of interleukin 2 and interleukin 4 on the tumorigenicity and treatment of B16F10 melanomaS J Hollingsworth, D Darling, J Gäken, et al.
Cancer Genetics and Cytogenetics|January 12, 2005
Isochromosome of a deleted 20q: a rare but recurrent chromosome abnormality in myelodysplastic syndromesK Saunders, B Czepulkowski, R Sivalingam, et al.
Leukemia Research|January 1, 1987
Differentiation induction in myelodysplasia and acute myeloid leukaemia: use of synergistic drug combinationsG E Francis, G J Mufti, S M Knowles, et al.
Oncogene|May 5, 2010
Reducing MCM levels in human primary T cells during the G(0)-->G(1) transition causes genomic instability during the first cell cycleS J Orr, T Gaymes, D Ladon, et al.
European Journal of Haematology|November 30, 2005
Cardiac presentation of ALK positive anaplastic large cell lymphomaZ Y Lim, R Grace, J R Salisbury, et al.
Bone Marrow Transplantation|February 27, 2007
Sarcoidosis as an unusual cause of hepatic dysfunction following reduced intensity conditioned allogeneic stem cell transplantationL Gooneratne, Z Y Lim, A du Vivier, et al.
Bone Marrow Transplantation|January 26, 2010
Allogeneic haematopoietic SCT for chronic myelomonocytic leukaemia: a single-centre experienceP Krishnamurthy, Z Y Lim, W Nagi, et al.
Leukemia Research|December 1, 2009
Impact of pre-transplant serum ferritin on outcomes of patients with myelodysplastic syndromes or secondary acute myeloid leukaemia receiving reduced intensity conditioning allogeneic haematopoietic stem cell transplantationZ Y Lim, V Fiaccadori, S Gandhi, et al.
The British Journal of Dermatology|April 11, 2007
Sclerodermatous graft-versus-host disease: clinical spectrum and therapeutic challengesJ M L White, D Creamer, A W P du Vivier, et al.
Blood|January 1, 1989
Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell originJ W Janssen, M Buschle, M Layton, et al.
Pageof 21